Imperial College London

DrDeepaJayakody Arachchillage

Faculty of MedicineDepartment of Immunology and Inflammation

Honorary Clinical Senior Lecturer



+44 (0)20 3313 4236d.arachchillage




Commonwealth BuildingHammersmith Campus





Dr Arachchillage is a consultant haematologist specialised in Haemostasis and Thrombosis and an honorary senior lecturer. She was awarded MRC CARP fellowship in 2021.

She completed MD (res) at the University College London in July 2015 on antiphospholipid syndrome (APS), complement activation and direct acting oral anticoagulants. She is the founder of antiphospholipid syndrome clinic at Hammersmith Hospital.

Her principal research interests are inflammation, endothelial dysfunction, effect of oral anticoagulant types on the coagulant phenotype of vascular endothelium and thrombosis, autoimmune thrombotic disorders including antiphospholipid syndrome, anticoagulation and acquired bleeding disorders mainly related to cardiac surgeries and extra corporeal membrane oxygenation (ECMO) in both paediatric and adults.  She has published over 80 peer reviewed high impact factor journal publications and six book chapters in the field of haemostasis and thrombosis. She is chief /principal investigator in number of clinal and translational research studies.

She is a member of the British Society for Haematologists’ haemostasis and thrombosis Task Force and has contributed for national and international guidelines.

She is a member of Research Advisory Group for autoimmune rheumatic diseases for Versus Arthritis, UK, and a member of International Extracorporeal life support (ECLS) Scientific Oversight Committee.

As a recognition of her contribution to research, she was awarded National Institute of Heath and Research (NIHR) and British Society for Haematology (BSH) researcher of the year 2021 and runner up of the outstanding individual of the NIHR CRN



Arachchillage DJ, Pericleous C, 2023, Evolution of Antiphospholipid Syndrome., Semin Thromb Hemost

Arachchillage DJ, Laffan M, Pericleous C, 2023, Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome., Int J Mol Sci, Vol:24

Jayakody Arachchillage D, Rajakaruna I, Pericleous C, et al., 2022, Autoimmune disease and COVID-19- a multicentre observational study in the United Kingdom, Rheumatology, Vol:61, ISSN:1462-0324, Pages:4643-4655

Arachchillage DJ, Crossette-Thambiah C, Asmar N, et al., 2022, Cerebral vein thrombosis after ChAdOx1 nCov-19 vaccination: Long-term outcome of four patients, Research and Practice in Thrombosis and Haemostasis, Vol:6

Bekono-Nessah I, Rosenburg A, Bowles CT, et al., 2022, Bleeding and thrombotic complications and their impact on mortality in patients supported with left ventricular assist device for cardiogenic shock, Perfusion-uk, ISSN:0267-6591

More Publications